Join the club for FREE to access the whole archive and other member benefits.
Key points from article :
We are at an inflection point for the treatment of aging.
We can generate molecules with specific molecular properties.
The biotech will also look to effect change in the mitochondria.
Expects to raise $20-50 million raised from friends-and-family this year.
Click on resource name for more details.
CEO of InSilico Medicine & Deep Longevity. CSO of Biogerontology Research Foundation
British entrepreneur, author and philanthropist with interests across a number of industries
The book written by Jim Mellon & Al Chalabi investigates the new technologies and explains how to benefit from the life extending technologies
